Having gastroesophageal reflux disease is associated with an increased risk for colonic neoplasia, including colon polyps and ...

Gastroesophageal reflux disease (GERD) interferes with our daily life with symptoms of heartburn, discomfort, and bloating.

Dr Ray O’Connor takes a look at the latest clinical articles on Gastro Oesophageal Reflux Disease, and its diagnosis and ...

“Some women in midlife experience these symptoms more intensely, potentially due to increased visceral sensitivity, changes ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

Stress doesn't directly cause GERD but can worsen symptoms by affecting digestion and increasing stomach acid production.

One specific kind of acid reflux, laryngopharyngeal reflux, can cause lesser-known symptoms like coughing, hoarseness, and a ...

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...

Aasif Khan, known for his role in Panchayat, addresses rumours about his recent health scare, confirming it was not a heart ...

Recently, as the prescription of GLP-1 receptor agonists, which is in the spotlight as a treatment for obesity, side effects ...

The Peptide Therapeutics Market value was US$ $$ billion in 2022. The Peptide Therapeutics Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...